Impairment of Retrograde Neuronal Transport in Oxaliplatin-induced Neuropathy Demonstrated by Molecular Imaging

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Oct 3

PMID 23029238

Citations 10

Authors

Dawid Schellingerhout

Lucia G LeRoux

Brian P Hobbs

Sebastian Bredow

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: The purpose of our study was to utilize a molecular imaging technology based on the retrograde axonal transport mechanism (neurography), to determine if oxaliplatin-induced neurotoxicity affects retrograde axonal transport in an animal model.

Materials And Methods: Mice (n = 8/group) were injected with a cumulative dose of 30 mg/kg oxaliplatin (sufficient to induce neurotoxicity) or dextrose control injections. Intramuscular injections of Tetanus Toxin C-fragment (TTc) labeled with Alexa 790 fluorescent dye were done (15 ug/20 uL) in the left calf muscles, and in vivo fluorescent imaging performed (0-60 min) at baseline, and then weekly for 5 weeks, followed by 2-weekly imaging out to 9 weeks. Tissues were harvested for immunohistochemical analysis.

Results: With sham treatment, TTc transport causes fluorescent signal intensity over the thoracic spine to increase from 0 to 60 minutes after injection. On average, fluorescence signal increased 722%+/-117% (Mean+/-SD) from 0 to 60 minutes. Oxaliplatin treated animals had comparable transport at baseline (787%+/-140%), but transport rapidly decreased through the course of the study, falling to 363%+/-88%, 269%+/-96%, 191%+/-58%, 121%+/-39%, 75%+/-21% with each successive week and stabilizing around 57% (+/-15%) at 7 weeks. Statistically significant divergence occurred at approximately 3 weeks (p≤0.05, linear mixed-effects regression model). Quantitative immuno-fluorescence histology with a constant cutoff threshold showed reduced TTc in the spinal cord at 7 weeks for treated animals versus controls (5.2 Arbitrary Units +/-0.52 vs 7.1 AU +/-1.38, p<0.0004, T-test). There was no significant difference in neural cell mass between the two groups as shown with NeuN staining (10.2+/-1.21 vs 10.5 AU +/-1.53, p>0.56, T-test).

Conclusion: We show-for the first time to our knowledge-that neurographic in vivo molecular imaging can demonstrate imaging changes in a model of oxaliplatin-induced neuropathy. Impaired retrograde neural transport is suggested to be an important part of the pathophysiology of oxaliplatin-induced neuropathy.

Citing Articles

Molecular and Cellular Involvement in CIPN.

Kacem H, Cimini A, dAngelo M, Castelli V Biomedicines. 2024; 12(4).

PMID: 38672107 PMC: 11048589. DOI: 10.3390/biomedicines12040751.

Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence.

Park S, Cetinkaya-Fisgin A, Argyriou A, Hoke A, Cavaletti G, Alberti P J Neurol Neurosurg Psychiatry. 2023; 94(11):962-972.

PMID: 37015772 PMC: 10579520. DOI: 10.1136/jnnp-2021-328323.

Neurological Complications of Conventional and Novel Anticancer Treatments.

Alberti P, Salvalaggio A, Argyriou A, Bruna J, Visentin A, Cavaletti G Cancers (Basel). 2022; 14(24).

PMID: 36551575 PMC: 9776739. DOI: 10.3390/cancers14246088.

Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect.

Malacrida A, Semperboni S, Di Domizio A, Palmioli A, Broggi L, Airoldi C Sci Rep. 2021; 11(1):10523.

PMID: 34006972 PMC: 8131610. DOI: 10.1038/s41598-021-89856-3.

Axonal Transport as an In Vivo Biomarker for Retinal Neuropathy.

Le Roux L, Qiu X, Jacobsen M, Pagel M, Gammon S, Piwnica-Worms D Cells. 2020; 9(5).

PMID: 32456061 PMC: 7291064. DOI: 10.3390/cells9051298.

References

Fishman P, Carrigan D . Retrograde transneuronal transfer of the C-fragment of tetanus toxin. Brain Res. 1987; 406(1-2):275-9. DOI: 10.1016/0006-8993(87)90792-x. View

Bohnert S, Schiavo G . Tetanus toxin is transported in a novel neuronal compartment characterized by a specialized pH regulation. J Biol Chem. 2005; 280(51):42336-44. DOI: 10.1074/jbc.M506750200. View

Kawashiri T, Egashira N, Watanabe H, Ikegami Y, Hirakawa S, Mihara Y . Prevention of oxaliplatin-induced mechanical allodynia and neurodegeneration by neurotropin in the rat model. Eur J Pain. 2010; 15(4):344-50. DOI: 10.1016/j.ejpain.2010.08.006. View

Schmidt Y, Unger J, Bartke I, Reiter R . Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice. Exp Neurol. 1995; 132(1):16-23. DOI: 10.1016/0014-4886(95)90054-3. View

Scuteri A, Galimberti A, Ravasi M, Pasini S, Donzelli E, Cavaletti G . NGF protects dorsal root ganglion neurons from oxaliplatin by modulating JNK/Sapk and ERK1/2. Neurosci Lett. 2010; 486(3):141-5. DOI: 10.1016/j.neulet.2010.09.028. View

Bizzini B, Stoeckel K, Schwab M . An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems. J Neurochem. 1977; 28(3):529-42. DOI: 10.1111/j.1471-4159.1977.tb10423.x. View

Cavaletti G, Tredici G, Petruccioli M, Donde E, Tredici P, Marmiroli P . Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur J Cancer. 2001; 37(18):2457-63. DOI: 10.1016/s0959-8049(01)00300-8. View

Cavaletti G, Marzorati L, Bogliun G, Colombo N, Marzola M, Pittelli M . Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity. Cancer. 1992; 69(1):203-7. DOI: 10.1002/1097-0142(19920101)69:1<203::aid-cncr2820690133>3.0.co;2-1. View

Stockel K, Schwab M, Thoenen H . Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons. Brain Res. 1975; 99(1):1-16. DOI: 10.1016/0006-8993(75)90604-6. View

10.

Schellingerhout D, Le Roux L, Bredow S, Gelovani J . Fluorescence imaging of fast retrograde axonal transport in living animals. Mol Imaging. 2009; 8(6):319-29. View

11.

Cavaletti G, Petruccioli M, Tredici G, Marmiroli P, Barajon I, Fabbrica D . Effects of repeated administration of low doses of cisplatin on the rat nervous system. Int J Tissue React. 1991; 13(3):151-7. View

12.

Troyan S, Kianzad V, Gibbs-Strauss S, Gioux S, Matsui A, Oketokoun R . The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol. 2009; 16(10):2943-52. PMC: 2772055. DOI: 10.1245/s10434-009-0594-2. View

13.

Cavaletti G, Tredici G, Marmiroli P, Petruccioli M, Barajon I, Fabbrica D . Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol. 1992; 84(4):364-71. DOI: 10.1007/BF00227662. View

14.

Ta L, Low P, Windebank A . Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli. Mol Pain. 2009; 5:9. PMC: 2655284. DOI: 10.1186/1744-8069-5-9. View

15.

Wolpaw J, Chen X . The cerebellum in maintenance of a motor skill: a hierarchy of brain and spinal cord plasticity underlies H-reflex conditioning. Learn Mem. 2006; 13(2):208-15. PMC: 1409832. DOI: 10.1101/lm.92706. View

16.

Nassini R, Gees M, Harrison S, De Siena G, Materazzi S, Moretto N . Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain. 2011; 152(7):1621-1631. DOI: 10.1016/j.pain.2011.02.051. View

17.

Zheng H, Xiao W, Bennett G . Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy. Exp Neurol. 2011; 232(2):154-61. PMC: 3202047. DOI: 10.1016/j.expneurol.2011.08.016. View

18.

Bizzini B, Grob P, Glicksman M, Akert K . Use of the B-IIb tetanus toxin derived fragment as a specific neuropharmacological transport agent. Brain Res. 1980; 193(1):221-7. DOI: 10.1016/0006-8993(80)90959-2. View

19.

Chen X, Wolpaw J . Probable corticospinal tract control of spinal cord plasticity in the rat. J Neurophysiol. 2002; 87(2):645-52. DOI: 10.1152/jn.00391.2001. View

20.

Xiao W, Zheng H, Zheng F, Nuydens R, Meert T, Bennett G . Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat. Neuroscience. 2011; 199:461-9. PMC: 3237950. DOI: 10.1016/j.neuroscience.2011.10.010. View